000			03309cam a2200337 a 4500
003			EG-GiCUC
005			20250223032805.0
008			210822s2021 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.21.02.Ph.D.2021.Sa.E
100	0		_aSandra Aziz Guirguis
245	1	0	_aEfficacy of sympathetic ganglion transcutaneous electrical nerve stimulation on leriche fontaine stage ii pripheral arterial disease / _cSandra Aziz Guirguis ; Supervised Heba Ahmed Ali Abdeen , Youssef Salah Sweify Aly
246	1	5	_aفعالية تحفيز العقدة الودية خلال العصب الكهربائى عبر الجلد على مرضى الشرايين الطرفية ليريش فونتين المرحلة الثانية
260			_aCairo : _bSandra Aziz Guirguis , _c2021
300			_a129 P. : _bcharts , facsimiles ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Physical Therapy - Department of Physical Therapy for Cardiopulmonary and Geiatrics Disorders
520			_aBackground: In patients with peripheral arterial disease (PAD), walking is often limited by early pain onset due to vascular claudication. Objective: The present study was designed to investigate the effect of application of transcutaneous electrical nerve stimulation on sympathetic ganglion on Leriche-Fontaine stage-II peripheral arterial disease patients. Methods : Forty patients were selected from outpatient vascular clinic from EL Sahel educational hospital with unilateral PAD (Leriche-Fontaine stage II), aged 50{u2013} 60 years of both sex participated in this study.They were randomly assigned into two groups equal in number A and B as following: Group A: received low-frequency TENS (frequency 4 Hz, pulse duration 200 os) applied through surface electrodes for 45 min per session, supramaximal stimulation to sympathetic ganglions in T12, L1, and L2, which innervate the lower extremity. For 45 min per session, three times per week for 12 weeks. Group B: the placebo stimulation was delivered as in group A but with a voltage level falling to zero for 10 sec of stimulation. Results: Group (A) showed significant increased percentage of ankle peak systolic velocity APSV by 40.32%, arterial diameter AD by 15.78%, intermittent claudication distance ICD by 60.76%, absolute claudication distance ACD by 153.27% and small significant decreased red blood cell distribution width RDW by 2.0% and mean platelet volume MPV by 3.96%. While group (B) showed non-significant increased percentage APSV 0.89% , AD by %5.5, ICD by 0.95%,ACD by 0.19% and non-significant decreased RDW by 0.26%, MPV by 0.35%.Conclusion:These results indicate that TENS application on sympathetic ganglion improves APSV, AD , ICD, ACD, RDW and MPV on Leriche-Fontaine stage-II peripheral arterial disease patients
530			_aIssued also as CD
653		4	_aPeripheral arterial disease
653		4	_aSympathetic ganglion
653		4	_aTranscutaneous electric nerve stimulation
700	0		_aHeba Ahmed Ali Abdeen , _eSupervisor
700	0		_aYoussef Salah Sweify Aly , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aShimaa _eCataloger
942			_2ddc _cTH
999			_c81794 _d81794